Fish oil cuts cholesterol in pro-footballers

28 April 2009

Fish oil given to professional football players has proven to be effective for improving cholesterol levels, according to a study  published in the January/February 2009 issue of Sports Health, A  Multidisciplinary Approach.

The patented fish oil supplement, Ultimate Omega from Nordic Naturals,  was administered to 36 professional football players aged 23 to 41 years  who volunteered to be randomly assigned to either the treatment or  control group in the study. "The results illustrated a rather dramatic  decrease in triglyceride levels, a healthy increase in HDL, and lowered  LDL in the athletes who used a moderately high dose of omega-3 EFA fish  oil," said Joseph Maroon, who serves on  Nordic Naturals' scientific  advisory board and a study researcher. This research adds to the  numerous publications that have shown fish oil to be a helpful  preventative measure for heart disease.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight